Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.6181
-0.0068 (-1.09%)
Oct 28, 2025, 4:00 PM EDT - Market closed
Rallybio Market Cap
Rallybio has a market cap or net worth of $25.83 million as of October 29, 2025. Its market cap has decreased by -43.91% in one year.
Market Cap
25.83M
Enterprise Value
-19.86M
1-Year Change
-43.91%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $25.83M, a decrease of -93.63%. That is a compound annual growth rate of -47.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 26.11M | -34.44% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
| Jul 29, 2021 | 405.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 401.96B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 250.89B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |